Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefdinir Granules

Approval Number

国药准字H20253255

Company广州江正医药科技有限公司

Registration Date

January 24, 2025

Drug Information

Generic Name

头孢地尼颗粒

Dosage Form

颗粒剂

Strength

50mg

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name广州江正医药科技有限公司

Company Address

广州市黄埔区科丰路33号20栋1010，1011房

Manufacturing Company

Company Name金鸿药业股份有限公司拱北分公司

Company Address

珠海市金海岸生物工业区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

头孢地尼颗粒 - NMPA 批准文号 | MedPath